JP2017506228A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017506228A5 JP2017506228A5 JP2016549799A JP2016549799A JP2017506228A5 JP 2017506228 A5 JP2017506228 A5 JP 2017506228A5 JP 2016549799 A JP2016549799 A JP 2016549799A JP 2016549799 A JP2016549799 A JP 2016549799A JP 2017506228 A5 JP2017506228 A5 JP 2017506228A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- mir
- seq
- protein
- precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091043249 miR-135-1 stem-loop Proteins 0.000 claims 31
- 108091064876 miR-135-2 stem-loop Proteins 0.000 claims 31
- 239000002243 precursor Substances 0.000 claims 18
- 230000014509 gene expression Effects 0.000 claims 14
- 108010078791 Carrier Proteins Proteins 0.000 claims 12
- 102000005962 receptors Human genes 0.000 claims 12
- 108020003175 receptors Proteins 0.000 claims 12
- 229940079593 drug Drugs 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 230000001419 dependent effect Effects 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 150000007523 nucleic acids Chemical class 0.000 claims 9
- 208000019022 Mood disease Diseases 0.000 claims 8
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 8
- 208000020925 Bipolar disease Diseases 0.000 claims 7
- 102100036817 Ankyrin-3 Human genes 0.000 claims 6
- 101710191051 Ankyrin-3 Proteins 0.000 claims 6
- 102000004190 Enzymes Human genes 0.000 claims 6
- 108090000790 Enzymes Proteins 0.000 claims 6
- 102000018899 Glutamate Receptors Human genes 0.000 claims 6
- 108010027915 Glutamate Receptors Proteins 0.000 claims 6
- 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 claims 6
- 102100038104 Glycogen synthase kinase-3 beta Human genes 0.000 claims 6
- 101000735539 Homo sapiens Pituitary adenylate cyclase-activating polypeptide Proteins 0.000 claims 6
- 102000004310 Ion Channels Human genes 0.000 claims 6
- 108090000862 Ion Channels Proteins 0.000 claims 6
- 102100023306 Nesprin-1 Human genes 0.000 claims 6
- 101710202335 Nesprin-1 Proteins 0.000 claims 6
- 108700020796 Oncogene Proteins 0.000 claims 6
- 108091000080 Phosphotransferase Proteins 0.000 claims 6
- 102100035733 Pituitary adenylate cyclase-activating polypeptide Human genes 0.000 claims 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 6
- 108010041191 Sirtuin 1 Proteins 0.000 claims 6
- 125000004122 cyclic group Chemical group 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 6
- 210000004498 neuroglial cell Anatomy 0.000 claims 6
- 102000020233 phosphotransferase Human genes 0.000 claims 6
- 229910052700 potassium Inorganic materials 0.000 claims 6
- 239000011591 potassium Substances 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 230000001430 anti-depressive effect Effects 0.000 claims 4
- 239000000935 antidepressant agent Substances 0.000 claims 4
- 229940005513 antidepressants Drugs 0.000 claims 4
- 230000002222 downregulating effect Effects 0.000 claims 4
- 229940076279 serotonin Drugs 0.000 claims 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims 3
- 102100021335 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 Human genes 0.000 claims 3
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 claims 3
- 101150095598 ADCYAP1 gene Proteins 0.000 claims 3
- 101150014463 ADRA2A gene Proteins 0.000 claims 3
- 102000007476 Activating Transcription Factor 3 Human genes 0.000 claims 3
- 108010085371 Activating Transcription Factor 3 Proteins 0.000 claims 3
- 101150027984 Adcyap1r1 gene Proteins 0.000 claims 3
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 claims 3
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 claims 3
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 claims 3
- 101150025500 CACNA1D gene Proteins 0.000 claims 3
- 101150118543 CSNK1G1 gene Proteins 0.000 claims 3
- 101150097016 Cadm3 gene Proteins 0.000 claims 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 3
- 102100024316 Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Human genes 0.000 claims 3
- 102000008122 Casein Kinase I Human genes 0.000 claims 3
- 108010049812 Casein Kinase I Proteins 0.000 claims 3
- 108091005462 Cation channels Proteins 0.000 claims 3
- 102100024046 Cell adhesion molecule 3 Human genes 0.000 claims 3
- 101710197433 Cell adhesion molecule 3 Proteins 0.000 claims 3
- 108091006146 Channels Proteins 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 3
- 101710137249 Complexin-1 Proteins 0.000 claims 3
- 102100027826 Complexin-1 Human genes 0.000 claims 3
- 101710137424 Complexin-2 Proteins 0.000 claims 3
- 102100027823 Complexin-2 Human genes 0.000 claims 3
- 101150092474 Cplx1 gene Proteins 0.000 claims 3
- 101150085998 Cplx2 gene Proteins 0.000 claims 3
- 101150065997 DLG2 gene Proteins 0.000 claims 3
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 claims 3
- 101150033452 Elk1 gene Proteins 0.000 claims 3
- 101150087304 Fut9 gene Proteins 0.000 claims 3
- 108020001289 G protein-coupled receptor 3 Proteins 0.000 claims 3
- 102000004192 G-Protein-Coupled Receptor Kinase 5 Human genes 0.000 claims 3
- 108010056586 G-Protein-Coupled Receptor Kinase 5 Proteins 0.000 claims 3
- 102100033047 G-protein coupled receptor 3 Human genes 0.000 claims 3
- 101150013958 GABRB2 gene Proteins 0.000 claims 3
- 102100037949 GTP-binding protein Di-Ras2 Human genes 0.000 claims 3
- 101150083770 Gpr3 gene Proteins 0.000 claims 3
- 101150084194 Grik3 gene Proteins 0.000 claims 3
- 101150033606 Grk5 gene Proteins 0.000 claims 3
- 101150102932 HCN1 gene Proteins 0.000 claims 3
- 101150038687 HCN2 gene Proteins 0.000 claims 3
- 101150015707 HTR1A gene Proteins 0.000 claims 3
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 claims 3
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 claims 3
- 102100024229 High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B Human genes 0.000 claims 3
- 101000819503 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 Proteins 0.000 claims 3
- 101000822895 Homo sapiens 5-hydroxytryptamine receptor 1A Proteins 0.000 claims 3
- 101000951231 Homo sapiens GTP-binding protein Di-Ras2 Proteins 0.000 claims 3
- 101001117263 Homo sapiens High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B Proteins 0.000 claims 3
- 101001001473 Homo sapiens Importin subunit alpha-4 Proteins 0.000 claims 3
- 101000615613 Homo sapiens Mineralocorticoid receptor Proteins 0.000 claims 3
- 101000588269 Homo sapiens Myelin transcription factor 1-like protein Proteins 0.000 claims 3
- 101000604463 Homo sapiens Netrin-G1 Proteins 0.000 claims 3
- 101000604469 Homo sapiens Netrin-G2 Proteins 0.000 claims 3
- 101000720704 Homo sapiens Neuronal migration protein doublecortin Proteins 0.000 claims 3
- 101000974009 Homo sapiens Nitric oxide synthase, brain Proteins 0.000 claims 3
- 101001137535 Homo sapiens Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Proteins 0.000 claims 3
- 101000584908 Homo sapiens Ras-related protein Rab-1B Proteins 0.000 claims 3
- 101001026232 Homo sapiens Small conductance calcium-activated potassium channel protein 3 Proteins 0.000 claims 3
- 101000712600 Homo sapiens Thyroid hormone receptor beta Proteins 0.000 claims 3
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 claims 3
- 101000867817 Homo sapiens Voltage-dependent L-type calcium channel subunit alpha-1D Proteins 0.000 claims 3
- 101001098805 Homo sapiens cAMP-specific 3',5'-cyclic phosphodiesterase 4A Proteins 0.000 claims 3
- 102100036187 Importin subunit alpha-4 Human genes 0.000 claims 3
- 101150007354 KALRN gene Proteins 0.000 claims 3
- 101710169959 Membrane protein 2 Proteins 0.000 claims 3
- 102100021316 Mineralocorticoid receptor Human genes 0.000 claims 3
- 241000713333 Mouse mammary tumor virus Species 0.000 claims 3
- 101100140974 Mus musculus Arhgap6 gene Proteins 0.000 claims 3
- 101100013967 Mus musculus Gata3 gene Proteins 0.000 claims 3
- 101100407343 Mus musculus Pde9a gene Proteins 0.000 claims 3
- 101100309353 Mus musculus Slc12a6 gene Proteins 0.000 claims 3
- 101100480205 Mus musculus Syt4 gene Proteins 0.000 claims 3
- 102100031623 Myelin transcription factor 1-like protein Human genes 0.000 claims 3
- 101150059596 Myt1l gene Proteins 0.000 claims 3
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 claims 3
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 claims 3
- 102100031455 NAD-dependent protein deacetylase sirtuin-1 Human genes 0.000 claims 3
- 101150003511 NR3C2 gene Proteins 0.000 claims 3
- 101150081663 Ncoa2 gene Proteins 0.000 claims 3
- 102100038699 Netrin-G2 Human genes 0.000 claims 3
- 102100025929 Neuronal migration protein doublecortin Human genes 0.000 claims 3
- 102000005665 Neurotransmitter Transport Proteins Human genes 0.000 claims 3
- 108010084810 Neurotransmitter Transport Proteins Proteins 0.000 claims 3
- 102100022397 Nitric oxide synthase, brain Human genes 0.000 claims 3
- 101150010049 Nucks1 gene Proteins 0.000 claims 3
- 108020005497 Nuclear hormone receptor Proteins 0.000 claims 3
- 102100039617 Nuclear receptor ROR-beta Human genes 0.000 claims 3
- 102100021007 Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Human genes 0.000 claims 3
- 101150085687 PLCB1 gene Proteins 0.000 claims 3
- 101150025468 Pde4a gene Proteins 0.000 claims 3
- 102000002808 Pituitary adenylate cyclase-activating polypeptide Human genes 0.000 claims 3
- 108010004684 Pituitary adenylate cyclase-activating polypeptide Proteins 0.000 claims 3
- 102000004257 Potassium Channel Human genes 0.000 claims 3
- 102100025067 Potassium voltage-gated channel subfamily H member 4 Human genes 0.000 claims 3
- 101710163352 Potassium voltage-gated channel subfamily H member 4 Proteins 0.000 claims 3
- 101150015730 Prlr gene Proteins 0.000 claims 3
- 108010002519 Prolactin Receptors Proteins 0.000 claims 3
- 102100029000 Prolactin receptor Human genes 0.000 claims 3
- 108091008730 RAR-related orphan receptors β Proteins 0.000 claims 3
- 101150105130 RORB gene Proteins 0.000 claims 3
- 101150049388 Rab1b gene Proteins 0.000 claims 3
- 102100029979 Ras-related protein Rab-1B Human genes 0.000 claims 3
- 102100031420 Ras-related protein Rap-2a Human genes 0.000 claims 3
- 101710116818 Ras-related protein Rap-2a Proteins 0.000 claims 3
- 101100287693 Rattus norvegicus Kcnh4 gene Proteins 0.000 claims 3
- 101100287705 Rattus norvegicus Kcnh8 gene Proteins 0.000 claims 3
- 108700005075 Regulator Genes Proteins 0.000 claims 3
- 102000016218 Rho GTPase-activating protein 6 Human genes 0.000 claims 3
- 108050004712 Rho GTPase-activating protein 6 Proteins 0.000 claims 3
- 108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 claims 3
- 108091006275 SLC5A7 Proteins 0.000 claims 3
- 101150064913 SV2B gene Proteins 0.000 claims 3
- 101150070676 SYT1 gene Proteins 0.000 claims 3
- 102000000344 Sirtuin 1 Human genes 0.000 claims 3
- 101150024537 Slc5a7 gene Proteins 0.000 claims 3
- 101150028423 Slc6a4 gene Proteins 0.000 claims 3
- 102100037442 Small conductance calcium-activated potassium channel protein 3 Human genes 0.000 claims 3
- 102100030700 Synaptic vesicle glycoprotein 2B Human genes 0.000 claims 3
- 101710084139 Synaptic vesicle glycoprotein 2B Proteins 0.000 claims 3
- 108010055170 Synaptotagmin I Proteins 0.000 claims 3
- 108010055445 Synaptotagmin II Proteins 0.000 claims 3
- 102100036417 Synaptotagmin-1 Human genes 0.000 claims 3
- 102100036151 Synaptotagmin-2 Human genes 0.000 claims 3
- 101150006549 Syt2 gene Proteins 0.000 claims 3
- 101150064314 Syt3 gene Proteins 0.000 claims 3
- 101150093886 TGFBR2 gene Proteins 0.000 claims 3
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 claims 3
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 claims 3
- 102000009618 Transforming Growth Factors Human genes 0.000 claims 3
- 108010009583 Transforming Growth Factors Proteins 0.000 claims 3
- 108010037572 Type 1 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 claims 3
- 102000014384 Type C Phospholipases Human genes 0.000 claims 3
- 108010079194 Type C Phospholipases Proteins 0.000 claims 3
- 101150026889 VAMP2 gene Proteins 0.000 claims 3
- 102000003786 Vesicle-associated membrane protein 2 Human genes 0.000 claims 3
- 102100032575 Voltage-dependent L-type calcium channel subunit alpha-1D Human genes 0.000 claims 3
- 102000052549 Wnt-3 Human genes 0.000 claims 3
- 108700020985 Wnt-3 Proteins 0.000 claims 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 3
- INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 230000004913 activation Effects 0.000 claims 3
- 102000035181 adaptor proteins Human genes 0.000 claims 3
- 108091005764 adaptor proteins Proteins 0.000 claims 3
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 claims 3
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 claims 3
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 claims 3
- 102000012740 beta Adrenergic Receptors Human genes 0.000 claims 3
- 108010079452 beta Adrenergic Receptors Proteins 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 102100037092 cAMP-specific 3',5'-cyclic phosphodiesterase 4A Human genes 0.000 claims 3
- 239000011575 calcium Substances 0.000 claims 3
- 229910052791 calcium Inorganic materials 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000008878 coupling Effects 0.000 claims 3
- 238000010168 coupling process Methods 0.000 claims 3
- 238000005859 coupling reaction Methods 0.000 claims 3
- 210000004292 cytoskeleton Anatomy 0.000 claims 3
- 230000000593 degrading effect Effects 0.000 claims 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims 3
- 102000009543 guanyl-nucleotide exchange factor activity proteins Human genes 0.000 claims 3
- 230000010354 integration Effects 0.000 claims 3
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 claims 3
- 230000013011 mating Effects 0.000 claims 3
- 238000012986 modification Methods 0.000 claims 3
- 230000004048 modification Effects 0.000 claims 3
- 210000000633 nuclear envelope Anatomy 0.000 claims 3
- 102000006255 nuclear receptors Human genes 0.000 claims 3
- 108020004017 nuclear receptors Proteins 0.000 claims 3
- 108020001213 potassium channel Proteins 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108700042226 ras Genes Proteins 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 230000000946 synaptic effect Effects 0.000 claims 3
- 210000002504 synaptic vesicle Anatomy 0.000 claims 3
- 102000003137 synaptotagmin Human genes 0.000 claims 3
- 108060008004 synaptotagmin Proteins 0.000 claims 3
- 101150072448 thrB gene Proteins 0.000 claims 3
- 238000013518 transcription Methods 0.000 claims 3
- 230000035897 transcription Effects 0.000 claims 3
- 239000011701 zinc Substances 0.000 claims 3
- 229910052725 zinc Inorganic materials 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 206010012335 Dependence Diseases 0.000 claims 1
- 208000030814 Eating disease Diseases 0.000 claims 1
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 206010033664 Panic attack Diseases 0.000 claims 1
- 108091093037 Peptide nucleic acid Proteins 0.000 claims 1
- 206010041250 Social phobia Diseases 0.000 claims 1
- 125000005600 alkyl phosphonate group Chemical group 0.000 claims 1
- 230000000561 anti-psychotic effect Effects 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 235000014632 disordered eating Nutrition 0.000 claims 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical compound OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 claims 1
- 206010016256 fatigue Diseases 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 claims 1
- 108091045872 miR-135 stem-loop Proteins 0.000 claims 1
- 108091026523 miR-135a stem-loop Proteins 0.000 claims 1
- 108091026375 miR-135b stem-loop Proteins 0.000 claims 1
- 108091086065 miR-135b-2 stem-loop Proteins 0.000 claims 1
- 108091070501 miRNA Proteins 0.000 claims 1
- 108091024443 miRa-135-1 stem-loop Proteins 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 239000004050 mood stabilizer Substances 0.000 claims 1
- 229940127237 mood stabilizer Drugs 0.000 claims 1
- 239000005022 packaging material Substances 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 208000019906 panic disease Diseases 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- -1 phosphate diester Chemical class 0.000 claims 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 claims 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461935912P | 2014-02-05 | 2014-02-05 | |
| US61/935,912 | 2014-02-05 | ||
| PCT/IL2015/050132 WO2015118537A2 (en) | 2014-02-05 | 2015-02-05 | Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019114138A Division JP2019172696A (ja) | 2014-02-05 | 2019-06-19 | セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017506228A JP2017506228A (ja) | 2017-03-02 |
| JP2017506228A5 true JP2017506228A5 (OSRAM) | 2018-03-15 |
Family
ID=52684603
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549799A Pending JP2017506228A (ja) | 2014-02-05 | 2015-02-05 | セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物 |
| JP2019114138A Pending JP2019172696A (ja) | 2014-02-05 | 2019-06-19 | セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物 |
| JP2020180055A Pending JP2021020951A (ja) | 2014-02-05 | 2020-10-28 | セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019114138A Pending JP2019172696A (ja) | 2014-02-05 | 2019-06-19 | セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物 |
| JP2020180055A Pending JP2021020951A (ja) | 2014-02-05 | 2020-10-28 | セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10125365B2 (OSRAM) |
| EP (1) | EP3102679B1 (OSRAM) |
| JP (3) | JP2017506228A (OSRAM) |
| CN (2) | CN106715695B (OSRAM) |
| CA (1) | CA2936158C (OSRAM) |
| IL (1) | IL246942B (OSRAM) |
| WO (1) | WO2015118537A2 (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013018060A2 (en) | 2011-08-04 | 2013-02-07 | Yeda Research And Development Co. Ltd. | Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
| CN106715695B (zh) | 2014-02-05 | 2020-07-31 | 耶达研究及发展有限公司 | 用于治疗和诊断的微rna和包含所述微rna的组合物 |
| WO2018151135A1 (ja) * | 2017-02-15 | 2018-08-23 | 国立研究開発法人医薬基盤・健康・栄養研究所 | 精神疾患モデル動物およびその製造方法 |
| CN111566212A (zh) | 2017-11-03 | 2020-08-21 | 因特尔纳技术有限公司 | miRNA分子，等同物，安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生 |
| EP3720434A4 (en) | 2017-12-05 | 2021-09-01 | Sunovion Pharmaceuticals Inc. | NON-RACEMIC MIXTURES AND THEIR USES |
| CN112236138B (zh) | 2017-12-05 | 2024-05-31 | 赛诺维信制药公司 | 晶体形式及其制备方法 |
| CN108409851B (zh) * | 2018-01-29 | 2020-12-08 | 上海交通大学 | 肾细胞癌中高水平表达的蛋白及其应用 |
| CA3019970A1 (en) * | 2018-10-05 | 2020-04-05 | Fang Liu | Methods for diagnosing or treating post-traumatic stress disorder, and compositions therefor |
| TWI703218B (zh) * | 2019-01-19 | 2020-09-01 | 高雄榮民總醫院 | 生物標記用以診斷第二型雙極症的用途 |
| MX2021014774A (es) | 2019-06-04 | 2022-02-03 | Sunovion Pharmaceuticals Inc | Formulaciones de liberacion modificada y usos de las mismas. |
| US20220340870A1 (en) * | 2019-09-10 | 2022-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Functional neuromodulatory assembloids |
| CN110585197B (zh) * | 2019-09-26 | 2023-02-17 | 上海交通大学 | 多巴胺受体拮抗剂泰尔登在治疗急性髓系白血病中的应用 |
| CN111172274B (zh) * | 2020-01-22 | 2021-10-15 | 清华大学 | Synaptotagmin-7在双向情感障碍诊断和治疗中的用途 |
| CN111440861B (zh) * | 2020-04-01 | 2022-11-04 | 上海市精神卫生中心（上海市心理咨询培训中心） | 甲基化的miR-124基因在制备用于诊断抑郁症的标志物中的用途 |
| JP2024503711A (ja) * | 2021-01-18 | 2024-01-26 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 修飾ｍｉＲ－１３５、そのコンジュゲートおよびその使用 |
| KR102570458B1 (ko) * | 2021-01-21 | 2023-08-24 | 전남대학교산학협력단 | 여성의 우울증 위험도 예측용 바이오마커, 상기 바이오마커를 이용한 여성의 우울증 위험도 진단에 대한 정보제공방법 및 진단키트 |
| JP7748047B2 (ja) * | 2021-08-23 | 2025-10-02 | 国立研究開発法人産業技術総合研究所 | 唾液中のうつ病バイオマーカー |
| CN114292851B (zh) * | 2022-01-12 | 2023-08-08 | 徐州医科大学 | 抑制Cnr1基因表达的干扰序列、shRNA慢病毒载体及构建方法和应用 |
| CN117737246B (zh) * | 2024-02-01 | 2025-01-28 | 首都医科大学附属北京天坛医院 | Plcb1基因作为生物标志物在侵袭性垂体腺瘤中的应用 |
Family Cites Families (108)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| US3687808A (en) | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
| US5023243A (en) | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
| US4476301A (en) | 1982-04-29 | 1984-10-09 | Centre National De La Recherche Scientifique | Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US5550111A (en) | 1984-07-11 | 1996-08-27 | Temple University-Of The Commonwealth System Of Higher Education | Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5405938A (en) | 1989-12-20 | 1995-04-11 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5276019A (en) | 1987-03-25 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
| US5264423A (en) | 1987-03-25 | 1993-11-23 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
| US5188897A (en) | 1987-10-22 | 1993-02-23 | Temple University Of The Commonwealth System Of Higher Education | Encapsulated 2',5'-phosphorothioate oligoadenylates |
| US4924624A (en) | 1987-10-22 | 1990-05-15 | Temple University-Of The Commonwealth System Of Higher Education | 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof |
| WO1989009221A1 (en) | 1988-03-25 | 1989-10-05 | University Of Virginia Alumni Patents Foundation | Oligonucleotide n-alkylphosphoramidates |
| US5278302A (en) | 1988-05-26 | 1994-01-11 | University Patents, Inc. | Polynucleotide phosphorodithioates |
| US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5399676A (en) | 1989-10-23 | 1995-03-21 | Gilead Sciences | Oligonucleotides with inverted polarity |
| US5264564A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
| US5264562A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences, Inc. | Oligonucleotide analogs with novel linkages |
| US5177198A (en) | 1989-11-30 | 1993-01-05 | University Of N.C. At Chapel Hill | Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
| US5587361A (en) | 1991-10-15 | 1996-12-24 | Isis Pharmaceuticals, Inc. | Oligonucleotides having phosphorothioate linkages of high chiral purity |
| US5321131A (en) | 1990-03-08 | 1994-06-14 | Hybridon, Inc. | Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling |
| US5470967A (en) | 1990-04-10 | 1995-11-28 | The Dupont Merck Pharmaceutical Company | Oligonucleotide analogs with sulfamate linkages |
| US5489677A (en) | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
| US5677437A (en) | 1990-07-27 | 1997-10-14 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
| US5610289A (en) | 1990-07-27 | 1997-03-11 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogues |
| US5623070A (en) | 1990-07-27 | 1997-04-22 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
| US5541307A (en) | 1990-07-27 | 1996-07-30 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
| US5618704A (en) | 1990-07-27 | 1997-04-08 | Isis Pharmacueticals, Inc. | Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling |
| US5608046A (en) | 1990-07-27 | 1997-03-04 | Isis Pharmaceuticals, Inc. | Conjugated 4'-desmethyl nucleoside analog compounds |
| US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
| PT98562B (pt) | 1990-08-03 | 1999-01-29 | Sanofi Sa | Processo para a preparacao de composicoes que compreendem sequencias de nucleo-sidos com cerca de 6 a cerca de 200 bases resistentes a nucleases |
| US5177196A (en) | 1990-08-16 | 1993-01-05 | Microprobe Corporation | Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| CA2089661C (en) | 1990-08-29 | 2007-04-03 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5214134A (en) | 1990-09-12 | 1993-05-25 | Sterling Winthrop Inc. | Process of linking nucleosides with a siloxane bridge |
| US5561225A (en) | 1990-09-19 | 1996-10-01 | Southern Research Institute | Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages |
| AU662298B2 (en) | 1990-09-20 | 1995-08-31 | Gilead Sciences, Inc. | Modified internucleoside linkages |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US5571799A (en) | 1991-08-12 | 1996-11-05 | Basco, Ltd. | (2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response |
| US5633360A (en) | 1992-04-14 | 1997-05-27 | Gilead Sciences, Inc. | Oligonucleotide analogs capable of passive cell membrane permeation |
| US5434257A (en) | 1992-06-01 | 1995-07-18 | Gilead Sciences, Inc. | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| US5476925A (en) | 1993-02-01 | 1995-12-19 | Northwestern University | Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups |
| GB9304618D0 (en) | 1993-03-06 | 1993-04-21 | Ciba Geigy Ag | Chemical compounds |
| ATE160572T1 (de) | 1993-03-31 | 1997-12-15 | Sanofi Sa | Oligonucleotide mit amidverkettungen die phosphoesterverkettungen einsetzen |
| US5625050A (en) | 1994-03-31 | 1997-04-29 | Amgen Inc. | Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
| US5807718A (en) | 1994-12-02 | 1998-09-15 | The Scripps Research Institute | Enzymatic DNA molecules |
| AU755564B2 (en) | 1998-06-20 | 2002-12-12 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US6303374B1 (en) | 2000-01-18 | 2001-10-16 | Isis Pharmaceuticals Inc. | Antisense modulation of caspase 3 expression |
| KR100843703B1 (ko) | 2000-07-21 | 2008-07-04 | 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 | 양극성 장애에서의 조증을 치료하기 위한 벨프로익산 및 2-벨프로에닉산 아미드 유도체의 용도 |
| US10517883B2 (en) | 2003-06-27 | 2019-12-31 | Zuli Holdings Ltd. | Method of treating acute myocardial infarction |
| JP5192234B2 (ja) | 2004-08-10 | 2013-05-08 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 化学修飾オリゴヌクレオチド |
| ES2534302T3 (es) | 2004-11-12 | 2015-04-21 | Asuragen, Inc. | Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN |
| US20070213292A1 (en) | 2005-08-10 | 2007-09-13 | The Rockefeller University | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| CN101296702B (zh) | 2005-09-12 | 2012-11-28 | 俄亥俄州立大学研究基金会 | 用于诊断或治疗bcl2相关癌症的组合物和方法 |
| EP2369012A1 (en) | 2006-03-20 | 2011-09-28 | The Ohio State University Research Foundation | Micro-RNA fingerprints during human megakaryocytopoiesis |
| US20090307788A1 (en) | 2006-06-19 | 2009-12-10 | Kobenhavns Universitet | Ribozyme mediated stabilization of polynucleotides |
| CA2663962A1 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
| US20090092980A1 (en) | 2007-07-20 | 2009-04-09 | Christoph Arenz | miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES |
| ES2617877T3 (es) | 2007-08-27 | 2017-06-20 | 1Globe Health Institute Llc | Composiciones de ARN interferente asimétrico y uso de las mismas |
| US7993831B2 (en) | 2007-09-14 | 2011-08-09 | Asuragen, Inc. | Methods of normalization in microRNA detection assays |
| EP2235175A4 (en) | 2007-12-20 | 2012-04-25 | Angiochem Inc | POLYPEPTIDE-NUCLEIC ACID CONJUGATES AND USES THEREOF |
| EP2298359A1 (en) | 2008-06-04 | 2011-03-23 | Kyowa Hakko Kirin Co., Ltd. | Nucleic acid capable of controlling degranulation of mast cell |
| WO2010048123A2 (en) | 2008-10-20 | 2010-04-29 | Eckhardt S Gail | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| AU2009217433A1 (en) | 2009-03-05 | 2010-09-23 | Newcastle Innovation Limited | Diagnostic, prognostic and treatment methods |
| EP2416789B1 (en) | 2009-04-07 | 2017-06-21 | Velin-Pharma A/S | Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system |
| JP2012525146A (ja) | 2009-04-28 | 2012-10-22 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | 細胞透過のための過剰に荷電されたタンパク質 |
| CN101590243A (zh) | 2009-06-23 | 2009-12-02 | 暨南大学 | 微小rna在制备治疗和/或预防淋巴瘤药物中的应用 |
| DK2560687T3 (en) | 2010-04-19 | 2017-09-18 | Nlife Therapeutics S L | Preparations and Methods for Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types |
| EP3075396A1 (en) | 2010-10-17 | 2016-10-05 | Yeda Research and Development Co. Ltd. | Methods and compositions for the treatment of insulin-associated medical conditions |
| WO2013018060A2 (en) * | 2011-08-04 | 2013-02-07 | Yeda Research And Development Co. Ltd. | Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
| WO2013116589A1 (en) * | 2012-02-02 | 2013-08-08 | St. Jude Children's Research Hospital | Methods for diagnosing and treating learning or mental disorders |
| JP2016503394A (ja) | 2012-10-26 | 2016-02-04 | エヌライフ、セラピューティックス、ソシエダッド、リミターダＮｌｉｆｅ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｓ．Ｌ． | 細胞型へのオリゴヌクレオチド分子の選択的送達のための組成物および方法 |
| MX2015005352A (es) | 2012-10-26 | 2015-10-29 | Nlife Therapeutics S L | Composiciones y métodos para el tratamiento de la enfermedad de parkinson mediante la administración selectiva de moléculas de oligonucleótidos a tipos específicos de neuronas. |
| CN106715695B (zh) | 2014-02-05 | 2020-07-31 | 耶达研究及发展有限公司 | 用于治疗和诊断的微rna和包含所述微rna的组合物 |
| JP2024503711A (ja) | 2021-01-18 | 2024-01-26 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 修飾ｍｉＲ－１３５、そのコンジュゲートおよびその使用 |
-
2015
- 2015-02-05 CN CN201580018229.0A patent/CN106715695B/zh active Active
- 2015-02-05 JP JP2016549799A patent/JP2017506228A/ja active Pending
- 2015-02-05 CN CN202010626254.XA patent/CN111733231A/zh active Pending
- 2015-02-05 WO PCT/IL2015/050132 patent/WO2015118537A2/en not_active Ceased
- 2015-02-05 CA CA2936158A patent/CA2936158C/en active Active
- 2015-02-05 US US15/111,539 patent/US10125365B2/en active Active
- 2015-02-05 EP EP15710264.1A patent/EP3102679B1/en active Active
-
2016
- 2016-07-25 IL IL246942A patent/IL246942B/en active IP Right Grant
-
2018
- 2018-11-05 US US16/180,083 patent/US10975373B2/en active Active
-
2019
- 2019-06-19 JP JP2019114138A patent/JP2019172696A/ja active Pending
-
2020
- 2020-10-28 JP JP2020180055A patent/JP2021020951A/ja active Pending
-
2021
- 2021-04-12 US US17/227,483 patent/US11680263B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017506228A5 (OSRAM) | ||
| US12016876B2 (en) | Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions | |
| JP7049249B2 (ja) | 中枢神経系疾患の処置のための組成物および方法 | |
| Yu et al. | MSX3 switches microglia polarization and protects from inflammation-induced demyelination | |
| US9089589B2 (en) | Micro-RNAs modulating immunity and inflammation | |
| AU2011219029B2 (en) | Methods and compositions for the detection and treatment of cancer involving miRNAs and miRNA inhibitors and targets | |
| JP2019172696A (ja) | セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物 | |
| US20130177624A1 (en) | Mirna expression in allergic disease | |
| CN104011208B (zh) | 作为治疗靶的miRNA-212/132家族 | |
| WO2014121083A1 (en) | Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition | |
| Tan et al. | MicroRNA-449a regulates the progression of brain aging by targeting SCN2B in SAMP8 mice | |
| Sierra et al. | The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome | |
| Vardimon et al. | Accumulation of c-src mRNA is developmentally regulated in embryonic neural retina | |
| CN103361427A (zh) | miRNA-219化合物在制备慢性疼痛诊断标志物及治疗药物中的应用 | |
| JP2021501594A (ja) | ニューロンの欠損に関連する状態及び／又は疾患を処置及び／又は診断するため、或いはニューロンの再生／発生のための、ｍｉＲＮＡ分子、等価物、アンタゴミル、又はそれらの供給源 | |
| Acton | Advances in Intracellular Space Research and Application: 2012 Edition: ScholarlyBrief | |
| WO2023077133A2 (en) | Controlling homeostatic regulatory circuitry in hypothalamus | |
| Kolenchery | Role of mir-483-5p in stress and anxiety | |
| Tsz Ying Sylvia | The roles of SH2-containing inositol 5'-phosphatase 1 (SHIP1) and signal transducer and activator of transcription 3 (STAT3) in interleukin-10 regulation of activated macrophages | |
| Romano | Analysis of the role of the transcription factor Slug in heart development |